Arcellx, Inc. (ACLX)
63.62
-1.51
(-2.32%)
USD |
NASDAQ |
Dec 30, 16:00
63.31
-0.31
(-0.49%)
After-Hours: 20:00
Arcellx Shareholders Equity (Quarterly): 440.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 21.54B |
| Johnson & Johnson | 79.28B |
| Amicus Therapeutics, Inc. | 230.42M |
| Relmada Therapeutics, Inc. | 9.466M |
| Invivyd, Inc. | 93.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 655.92M |
| Total Liabilities (Quarterly) | 215.14M |
| Debt to Equity Ratio | 0.1175 |
| Current Ratio | 3.987 |
| Net Debt Paydown Yield | 0.09% |